Ocrelizumab for multiple sclerosis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of ocrelizumab in people with relapsing‐remitting multiple sclerosis (RRMS) or primary progressive multiple sclerosis (PPMS).

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Lin, Mengbing, Shi, Shengliang, Zhang, Jian, Yang, Cheng Min, Luo, Jiefeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2019
Konular:
Medicine General & Introductory Medical Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6353045/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013247
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller